Higher Risk for Mental Disorders Seen in Patients With Psoriasis
Time to onset found to be 2 to 3 months for anxiety disorders and other conditions.
General Rheumatology
Lupus Affects Emotional, Mental Well-Being of Patients
Most patients report not having participated in a lupus clinical trial, despite interest.
CDC: Prevalence of Arthritis 22.8% in US Adults in 2017
Adults with arthritis in southeastern states have highest prevalence of severe joint pain, physical inactivity.
Disability Often Precedes Rheumatoid Arthritis Diagnosis
Functional disability continues even after diagnosis and treatment.
Breastfeeding Rates Lower Among Women With Rheumatoid Arthritis
Participants indicated that the main reason they discontinued breastfeeding was the restart of their medication.
First Treatment for Children With Systemic Lupus Erythematosus Gets FDA Approval
The Food and Drug Administration (FDA) has approved the intravenous (IV) formulation of Benlysta (belimumab; GlaxoSmithKline) for the treatment of pediatric patients ≥5 years old with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.
Infections May Up Risk for Developing Sjögren Syndrome
Lung, skin, urogenital infections tied to increased risk for developing primary Sjögren syndrome
Periodontal Disease and Rheumatoid Arthritis: How Are They Related?
Rheumatology Advisor interviewed Dr Sofat, who suggests that better control of periodontal disease might improve outcomes in rheumatoid arthritis.
ACR Issues Position Statements on Drug Pricing, Step Therapy
Two position statements developed in relation to drug pricing and step therapy have been issued by the American College of Rheumatology.
Managing Systemic Lupus Erythematosus: Updated 2019 EULAR Recommendations Released
EULAR has released updated 2019 recommendations for the management of systemic lupus erythematosus.
Next post in Rheumatology Information Center
